Oncology

Biomedical Research in Gynecology

Antonio Gil Moreno

Researchers Anna Santamaria Margalef, Xavier Santamaria, Ángel Garcia, Assumpció Pérez Benavente, Silvia Cabrera, Berta Díaz, José Luis Sánchez, Javier de la Torre, Cristina Centeno, Silvia Franco, María Elena Suárez, José Luis Poza, Blanca Gil, Sabina Salicrú, Montserrat Cubo, Sira Capote, Laura Mañalich, Cristian Moiola | Researchers in training Tatiana Altadill Vallespí, Irene Campoy Moncayo, Laura Devis Jauregui, Elena Martínez Garcia, Blanca Majem Cavaller, Júlia Vallvé Juanico, Lucia Lanau Angulo, Núria Masià, Alfonso Parrilla, Leire Rekalde, Maria Font, Ignacio Carcela, Dimitra-Maria Kasimi | Nursing, technical and administrative staff Gabriel Tamayo Ballesteros, Elisabet Olivan Riera

group-team-close
group-team group-zoom group-download

Summary

During 2015, the Biomedical Research Group in Gynaecology, led by Dr. Antonio Gil Moreno, also head of the Gynaecology Service of Vall Hebron Hospital, has consolidated its structure. Dr. Gil has managed to increase the already high crosstalk between clinicians and basic and translational researchers generating a more fruitful research environment. Apart from his duties as director of the group, Dr. Gil is mostly dedicated to endometrial cancer translational and clinical research within the group. Dr. Anna Santamaria, recipient of a Miguel Servet Grant since 2014, leads the ovarian cancer research line and Dr. Xavier Santamaria is responsible together with Dr. Gil of the endometriosis research line.

As remarkable scientific achievements of 2015, we highlight the consecution of important national research grants that have allowed consolidating the ovarian cancer team, as well as maintaining the scientific track of the endometrial cancer research line. The group has established a Patient-Derived Tumor Xenograft (PDTX) Platform for Endometrial Cancer, which nowadays includes 44 PDTX models of different endometrial cancer types and grades. These models are clinically relevant for the pharmacological validation of targeted therapeutical approaches. In parallel, the group has performed a profound investment to improve diagnosis of endometrial cancer by exploring the diverse opportunities of uterine aspirates. Finally, the group has also obtained this year the important ESGO credentials for the formation of fellows in the Oncologist Gynecology and mammary pathology specialities.

Together, we are moving into a more directed research towards improving the management of endometrial and ovarian cancer patients, as well as endometriosis.

 

Publications

7
total
19.875
impact factor
2.839
average impact factor
Selected articles+

Main research projects

View+